Table III.
CD5-CK2 signaling pathway regulates TCR-induced apoptosis in T-cells
Anti- CD3 (μs/ml) |
%Annexin V+7-AAD− | MOG35-55 (μg/ml) |
%Annexin V+7-AAD− | ||||
---|---|---|---|---|---|---|---|
CD5WT | CD5KO | CD5ΔCK2BD | 2D2.CD5WT | 2D2.CD5KO | 2D2.CD5 ACK2BD | ||
0 | 9.7±1.3 | 10.7±1.8 | 9.8±0.3 | 0 | 15.0±1.1 | 27.0±3.6 | 26.2±2.8b |
0.1 | 9.6±0.7 | 10.9±0.1 | 9.5±0.7 | 1 | 19.6±0.6 | 39.7±2.1c,d | 35.9±1.5c |
1 | 8.8±0.6a | 14.0±1.3 | 9.6±0.7a | 10 | 33.1±0.3e | 43.1±2.6f | 46.9±7.6 |
100 | 31.4±0.5g | 39.0±2.2g,h | 71.4±4.4 |
Cells were stimulated with varying concentrations of anti-CD3 or MOG35-55 peptide in the presence of irradiated APCs for 24 h. Apoptosis was evaluated by staining cells with Annexin V and 7-AAD.
Data are presented as % of events ± SEM.
p<0.01; vs. CD5KO mice
p<0.05; 2D2.CD5ΔCK2BD vs. 2D2.CD5WT mice
p<0.001; vs. 2D2.CD5WT mice
p<0.05; 2D2.CD5KO mice vs. 2D2.CD5ΔCK2BD mice
p<0.01; 2D2.CD5WT mice vs. 2D2.CD5ΔCK2BD mice
p<0.05; 2D2.CD5KO mice vs. 2D2.CD5ΔCK2BD mice
p<0.001; vs. 2D2.CD5CK2BD mice
p<0.01; 2D2.CD5KO mice vs. 2D2.CD5WT mice